Removing both fallopian tubes during other pelvic surgeries can reduce a woman's risk of developing ovarian cancer by nearly 80% [2].
This finding shifts the understanding of ovarian cancer origins. Because the majority of high-grade serous ovarian cancers begin in the fallopian tubes, removing them eliminates the primary site where these malignancies start [1].
The procedure, known as opportunistic bilateral salpingectomy, is typically performed at the same time as a hysterectomy [1]. Recent analyses of women who underwent the procedure over the last 10 years show a significant drop in cancer rates [1].
Data indicates that the risk reduction for serous ovarian cancer is nearly 80% [4]. Other reports specify the risk reduction at 78% [1].
Medical reports highlight a stark difference in the proportion of high-grade serous carcinomas between patients who had the procedure and a historical cohort, showing a rate of 23% compared to 68% [4].
"The vast majority of cases begin in the fallopian tubes — and removing them can reduce the risk by nearly 80 percent," a New York Times article said [2].
Doctors said the procedure is a viable preventative measure for women already undergoing surgery for other reasons [3]. By removing the tubes, surgeons target the specific tissue where most aggressive ovarian cancers originate [1].
“Removing both fallopian tubes during other pelvic surgeries can reduce a woman's risk of developing ovarian cancer by nearly 80%.”
This research reinforces a growing medical consensus that many 'ovarian' cancers are actually tubal in origin. By integrating salpingectomy into routine hysterectomies, surgeons can provide a significant preventative health benefit with minimal additional surgical time, potentially reducing the incidence of the most lethal forms of ovarian cancer.
